Weiwei Kong

机构：University of Electronic Science and Technology of China · ORCID：0000-0002-6548-1875

发表论文 80 篇 · 总被引 954 次 · h-index 16

代表论文

• PD-1 blockade plus chemoradiotherapy as preoperative therapy for patients with BRPC/LAPC: A biomolecular exploratory, phase II trial (2023 · Cell Reports Medicine · 被引 38)
• The Efficacy and Safety of Roxadustat for the Treatment of Posttransplantation Anemia: A Randomized Study (2024 · Kidney International Reports · 被引 19)
• Preparation of cationic waterborne polyurethane and its application in leather dyeing (2024 · Polymer · 被引 15)
• Kidney Renin Release under Hypoxia and Its Potential Link with Nitric Oxide: A Narrative Review (2023 · Biomedicines · 被引 10)
• Bombyx mori serpin 3 is involved in innate immunity by interacting with serine protease 7 to regulate prophenoloxidase activation (2024 · Journal of Invertebrate Pathology · 被引 9)
• Efficacy and safety of second-line therapy by S-1 combined with sintilimab and anlotinib in pancreatic cancer patients with liver metastasis: a single-arm, phase II clinical trial (2024 · Frontiers in Immunology · 被引 9)